Entera Bio Statistics

Total Valuation

Entera Bio has a market cap or net worth of $87.22 million. The enterprise value is $76.59 million.

Market Cap	87.22M
Enterprise Value	76.59M

Important Dates

The last earnings date was Friday, August 8, 2025, after market close.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Entera Bio has 45.66 million shares outstanding. The number of shares has increased by 28.63% in one year.

Current Share Class	45.45M
Shares Outstanding	45.66M
Shares Change (YoY)	+28.63%
Shares Change (QoQ)	+15.95%
Owned by Insiders (%)	1.97%
Owned by Institutions (%)	8.55%
Float	28.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	705.24
Forward PS	n/a
PB Ratio	5.51
P/TBV Ratio	5.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	617.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.47

Current Ratio	10.47
Quick Ratio	6.13
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -77.96% and return on invested capital (ROIC) is -48.27%.

Return on Equity (ROE)	-77.96%
Return on Assets (ROA)	-42.45%
Return on Invested Capital (ROIC)	-48.27%
Return on Capital Employed (ROCE)	-56.60%
Revenue Per Employee	$6,200
Profits Per Employee	-$502,600
Employee Count	20
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, Entera Bio has paid $14,000 in taxes.

Income Tax	14,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.36% in the last 52 weeks. The beta is 1.52, so Entera Bio's price volatility has been higher than the market average.

Beta (5Y)	1.52
52-Week Price Change	+24.36%
50-Day Moving Average	1.96
200-Day Moving Average	2.01
Relative Strength Index (RSI)	50.26
Average Volume (20 Days)	290,729

Short Selling Information

Short Interest	55,477
Short Previous Month	37,398
Short % of Shares Out	0.12%
Short % of Float	0.19%
Short Ratio (days to cover)	0.23

Income Statement

In the last 12 months, Entera Bio had revenue of $124,000 and -$10.05 million in losses. Loss per share was -$0.24.

Revenue	124,000
Gross Profit	1,000
Operating Income	-10.09M
Pretax Income	-8.51M
Net Income	-10.05M
EBITDA	-10.05M
EBIT	-10.09M
Loss Per Share	-$0.24

Full Income Statement

Balance Sheet

The company has $10.86 million in cash and n/a in debt, giving a net cash position of $10.86 million or $0.24 per share.

Cash & Cash Equivalents	10.86M
Total Debt	n/a
Net Cash	10.86M
Net Cash Per Share	$0.24
Equity (Book Value)	17.26M
Book Value Per Share	0.34
Working Capital	17.47M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	0.81%
Operating Margin	-8,134.68%
Pretax Margin	-8,095.16%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Entera Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.63%
Shareholder Yield	-28.63%
Earnings Yield	-11.49%
FCF Yield	n/a

Analyst Forecast

The average price target for Entera Bio is $10.00, which is 423.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	423.56%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2